US equities |
NVDA $237.16 ▲+1.37% MU $1,058.68 ▼-1.51% SPCX $164.56 ▲+3.52% MSFT $527.92 ▲+2.01% TSLA $376.25 ▲+1.53% INTC $116.48 ▼-2.38% SNDK $1,716.28 ▼-0.22% AMD $629.49 ▼-0.70%
FinancialContent

Articles published by F-star Therapeutics, Inc.

News headline image
F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies
From F-star Therapeutics, Inc.
Via GlobeNewswire
News headline image
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
invoX Pharma and F-star Therapeutics issue Joint Statement
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX
News headline image
F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research
From F-star Therapeutics, Inc.
Via GlobeNewswire
Tickers FSTX